Drug Trials Have Positive Outcomes when Funded by Drug Maker
It’s no surprise, really, that a study regarding the efficacy of a certain drug is going to be more positive if it’s funded by the drug’s manufacturer rather than some other entity that does not stand to profit from sale of the drug. According to a recent study, researchers found this shocking assertion to be true after reviewing 546 drug trials and finding that industry-funded trials reported positive results 85% of the time compared to 50% of the time in government-funded trials.
In trials funded by non-federal organizations or nonprofits, a positive outcome was reported 72% of the time; among those that received contributions from the drug maker, reviews were more likely to be positive (85%) compared to those without industry support (61%).
This report was published Monday, August 2, 2010 in the Annals of Internal Medicine.
If you or a loved one has been harmed by a dangerous or defective drug anywhere in the United States, please contact the pharmaceutical litigation attorneys at Schlichter, Bogard & Denton today.